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Objective: To assess whether the number of daily administrations of individual drugs, as a 
measure of regimen complexity, contributes to the proﬁ  le of an elderly patient who adheres 
poorly to the prescribed therapy.
Population: Six hundred ninety patients over 64 years who were consecutively admitted to 
11 acute medical care and three long term/rehabilitation wards in Italy.
Main outcome measure: Self-reported adherence to drugs taken at home before admission 
was measured by a single question assessment for each listed drug supplemented with a latter 
question about the circumstances of the missed administration. For cognitively impaired patients 
the question was put to patients’ relatives or caregivers.
Methods: A structured multidimensional assessment was performed to identify nonadher-
ence and its potential correlates. Correlates of nonadherence were identiﬁ  ed by multivariable 
logistic regression.
Results: We recorded 44 cases (6.4%) of nonadherence to at least one drug. Being assisted by 
foreign caregivers (OR 2.17; 95% CI 1.02–4.63) and the use of at least one multiple daily dos-
ing drug (OR 2.99; 95% CI 1.24–7.17) were signiﬁ  cant independent correlates of medication 
nonadherence, while age, selected indexes of frailty and the cumulative number of prescribed 
drugs were not.
Conclusion: Regimen complexity and type of assistance are independent correlates of medi-
cation nonadherence.
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Introduction
Poor adherence to the prescribed therapy has been repeatedly reported to be highly 
prevalent in different settings and populations.1–5 It largely contributes to explain why 
control of hypertension or of diabetes is frequently unsatisfactory and, thus, it has major 
health care and economic implications.3,5–7 Accordingly, many authors have tried to 
proﬁ  le the noncompliant patient in order to predispose preventive interventions.5,8–14 
Results vary with the studied population and the method used. For instance, younger 
patients are more likely to be noncompliant in diabetic,5 but not in hypertensive 
populations.8,11 Overall, elderly and female gender are recurring nonmodiﬁ  able cor-
relates of poor compliance,8,15 although discordant results have been reported.9,10 Lower 
educational level, less afﬂ  uent economic status, cognitive/physical impairment and 
some diseases such as chronic renal failure are commonly reported poorly modiﬁ  able 
correlates of nonadherence.8,10,12,16,17 On the other hand, regimen complexity, as reﬂ  ected 
by the number of prescribed drugs, represents an important and to some extent modiﬁ  -
able correlate of the outcome.18,19 Thus, attempts at reducing the number of prescribed 
drugs, also to prevent adverse drug reactions, are highly recommendable, especially 
in elderly patients. However, despite the bulk of clinical and epidemiological studies, 
some grey areas still exist in the understanding of factors related to poor compliance 
in elderly population. First, assessing regimen complexity on the basis of the number Therapeutics and Clinical Risk Management 2009:5 210
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of drugs likely misses “intrinsic complexity,” ie, the one 
related to the structure of the therapy. For instance, taking 
eight different pills corresponding to eight different drugs 
daily likely is less demanding than taking eight pills three of 
which are fractionated doses of the same drug. Furthermore, 
periodically administered drugs, eg, once a week or every 
other day, are a further source of regimen complexity and, 
then, a potential risk factor for nonadherence.
In the context of a pharmacosurveillance study, we per-
formed an ancillary study assessing whether and to which 
extent a previously unexplored measure of regimen complexity, 
ie, the number of daily administrations of individual drugs, 
contribute to proﬁ  le the elderly patient who adheres poorly to 
the prescribed therapy. We weighed this potential correlate by 
correcting the statistical model for previously recognized risk 
factors for poor adherence as well as for the source of informal 
support. Indeed, we reasoned that provision of care by foreign 
caregivers might affect the adherence to therapy because of 
cultural, eg, medication beliefs, and language problems.
Methods
The present study uses data from a collaborative observational 
study group, the Pharmacosurveillance in the Elderly Care 
(PVC) study, based in community and university hospitals 
located throughout Italy, aimed at surveying drug consump-
tion, prevalence and correlates of potentially inappropriate 
prescribing, occurrence of adverse drug reactions, and quality 
of hospital care.
All patients consecutively admitted to the participating 
wards (11 acute care medical wards and three long-term 
care/rehabilitation units) from April 1st to June 30th 2007 
were asked to participate in the study. After obtaining a 
written informed consent, a study physician with speciﬁ  c 
training completed a questionnaire for each patient at admis-
sion to hospital and updated it daily. Data recorded included 
sociodemographic characteristics, medical variables, com-
plete blood count, neuropsychological and physical function 
variables.20–30
Overall, 762 patients were initially screened in the survey 
period, but 72 (9.4%) refused to participate, which left a ﬁ  nal 
sample of 690 patients. In the present study we used only 
data collected from the admission to discharge. The study 
protocol was approved by the Ethical Committee of the Italian 
National Research Center on Aging (INRCA).
Analytic approach
The main outcome of our study was the self-reported 
adherence to drugs taken at home before admission.31 For each 
drug used before the admission, patients were asked the single 
question about medication adherence: “Have you missed any 
pills in the last week?” Such a single-question assessment has 
been reported to have 50% speciﬁ  city and 87% sensitivity for 
adherence.31 In order to improve its diagnostic accuracy, it was 
supplemented with a latter question about the circumstances of 
the missed administration: a drug missed for medical reasons, 
eg, an antidiabetic pill missed because of hypoglycemia, was 
not considered as nonadherence. For cognitively impaired 
patients (age- and education-adjusted Mini-Mental State 
Exam [MMSE] score less than 24), the question was asked 
to patient’s relatives or caregivers. An analytical variable was 
created to identify patients with self-reported nonadherence 
for at least one drug taken before admission.
Variables speciﬁ  cally considered in this study were age, 
gender, years of education, living arrangement, smoking 
habit, alcohol consumption, type of ward, low self-reported 
income, need of economic help for health expenses, informal 
and formal assistance.
Cognitive impairment was ascertained on the basis of 
MMSE score and was considered as a potential confounder 
in the analysis. Functional capabilities were rated by basic 
(BADL) and instrumental activities of daily living (IADL) 
scales. Patients were categorized as independent (no need of 
assistance in any activity) or dependent (needs assistance in at 
least one activity) separately for BADL and IADL. Patients 
with Geriatric Depression Scale (GDS) score greater than 5 
were considered to have depressive symptoms. Comorbidity 
was rated by Cumulative Illness Rating Scale (CIRS) and two 
scores were calculated: a) the severity score, which reﬂ  ects 
the overall burden of illness, is based on the mean of the 
ratings across all disease categories, and b) the comorbidity 
score, which reﬂ  ects the diversity of illnesses, is the total 
number of categories in which moderate or severe levels of 
pathology are noted (range 0 to 13).
Diagnoses were coded using the International Clas-
siﬁ  cation of Disease 9th Edition – Clinical Modiﬁ  cation 
(ICD9-CM). The most frequent any-listed and ﬁ  rst-listed 
diagnoses were separately considered in the analyses. The 
overall number of drugs was calculated and considered as 
a potential correlate of the outcome. Finally, in order to 
investigate the impact of regimen complexity on medication 
adherence, the following medication-related measures were 
considered in the analysis: the use of at least one multiple 
daily dosing drug (ie, patients who must take the same drug 
more than once a day), the use of at least one drug taken 
less than once-a-day (eg, every other day), and the use of 
subcutaneous or inhaled drug.Therapeutics and Clinical Risk Management 2009:5 211
Regimen complexity and medication nonadherence in elderly patients
Statistical analysis
We used unadjusted odds ratios (OR) to compare the 
sociodemographic and clinical characteristics of patients 
divided according to the self-reported nonadherence to at 
least one of the drugs taken at home. Age, gender, and vari-
ables signiﬁ  cantly distinguishing groups at p   0.1 levels 
in initial analysis were entered into a multivariable logistic 
regression model to obtain a deconfounded estimate of the 
correlates of the outcome. The Hosmer and Lemeshow test 
was used to measure the goodness of ﬁ  t of the model.32 The 
possibility of interactions between overall number of drugs 
and measures of medication regimen complexity was also 
examined. All statistical analyses were performed using 
SPSS software (version 10.0; SPSS Inc., Chicago, IL).
Results
We recorded 44 cases of nonadherence to at least one drug, 
corresponding to a prevalence of 6.4%. Nonadherence was 
associated with a slightly higher prevalence of cognitive 
impairment and assistance provided by foreign caregivers 
with respect to patients reporting regular adherence to all 
drugs. Among cognitive deficits examined by MMSE, 
impaired orientation to time (27.3 vs 15.6, p = 0.044) and, 
to a lesser extent, orientation to place (22.7% vs 13.5%, 
p = 0.087), and memory recall (38.6% vs 26.0%, p = 0.067) 
were more frequent among nonadherent patients. Groups of 
adherents and nonadherents were comparable as regards age, 
gender, living arrangement, functional performance, mood, 
socioeconomic status, and type of admission ward. Renal 
failure and, to a lesser extent, diabetes mellitus and ﬁ  rst-
listed diagnosis of pneumonia were more prevalent among 
nonadherent patients, while ﬁ  rst-listed chronic obstructive 
pulmonary disease was less frequent among nonadherent 
patients. The CIRS severity score was higher in nonadherent 
with respect to adherent patients, while the overall number 
of drugs taken at home did not distinguish groups. Finally, 
regimen complexity, ie, taking multiple daily doses of a 
given drug, was more frequent among nonadherent patients 
(Table 1).
Summary logistic regression analysis showed that being 
assisted by foreign caregivers and regimen complexity were 
signiﬁ  cant independent correlates of medication nonadher-
ence (Table 2). The nonsigniﬁ  cant (p = 0.422) Hosmer and 
Lemeshow test was consistent with a satisfactory goodness 
of ﬁ  t. Similar results were obtained when impaired orien-
tation and memory recall were considered in the analysis 
instead of overall MMSE score. Furthermore, there was no 
interactions between the two medication-related measures 
(overall number of drugs  5 and use of at least one multiple 
daily dosing drugs) admitted to the ﬁ  nal logistic regression 
model (fully adjusted OR 1.42; 95% conﬁ  dence interval [CI] 
0.73–2.76; p = 0.297).
Finally, patients assisted by foreign caregivers were 
older (age 85 years or more: 28.6% vs 19.3%, p = 0.048) and 
more frequently were female (71.4% vs 54.2%, p = 0.001), 
and had a greater prevalence of physical (dependence in at 
least one BADL: 62.9% vs 25.3%, p = 0.001; dependence 
in three or more IADL 91.4% vs 68.0%, p = 0.001) and 
cognitive impairment (71.4% vs 50.6%, p = 0.001), but had 
similar need for economic help (13.3% vs 8.9%, p = 0.154), 
and low self-reported income (38.1% vs 33.5%, p = 0.361) 
with respect to patients not assisted by foreign caregivers. 
However, none of these variables was individually correlated 
with the nonadherence outcome.
Discussion
The main ﬁ  nding from our study is that in an elderly population 
regimen complexity, as expressed by the use of at least one 
multiple daily dose drug, and provision of care by a foreign 
caregiver are associated with lower adherence to medications, 
while the overall number of drugs and age are not.
Thus, complex medication regimens may contribute 
to nonadherence more than the overall number of taken 
drugs. Conceptually, therapeutic regimen factors, such as 
multiple daily dosing and pill burden (eg, the necessity to 
cut tablets) could signiﬁ  cantly impact medication adher-
ence, particularly in elderly patients. Surprisingly, only few 
studies considered regimen factors as potential correlates of 
nonadherence.14,33 On the contrary, polypharmacy per se has 
been extensively studied in relation to medication adherence 
and it has been reported to be associated with nonadherence 
by Vik and colleagues and Lexchin and colleagues,18,19 but 
not in other studies.9,34 Patient-related factors, such as vision 
impairment and/or reduced manual dexterity, and patients’ 
perception of medication importance may contribute to 
determine the relationship between regimen complexity and 
nonadherence.35,36
The provision of care by a foreign caregiver is a formerly 
unexplored item in the study of medication nonadherence. 
Foreign workers of lower socioeconomic status who provide 
care to more afﬂ  uent, but frail older adults, represent a uni-
versal social phenomenon which poses many difﬁ  culties and 
challenges. These are partially due to very prominent cultural 
differences between the host culture and the culture of the 
home care worker, and they are also due to legal, social, and 
economic differences ingrained in such a care arrangement.37 Therapeutics and Clinical Risk Management 2009:5 212
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Table 1 Sociodemographic and clinical characteristics of patients divided according to medication adherence
Adherent 
N = 646
Nonadherent 
N = 44
Unadjusted OR 
(95% CI)
Age
   75 145 (22.4) 12 (27.3) 1.0
  75–84 368 (57.0) 22 (50.0) 0.72 (0.35–1.50)
  85 or more 133 (20.6) 10 (22.7) 0.91 (0.38–2.17)
Gender (F) 370 (57.3) 22 (50.0) 0.75 (0.40–1.37)
Years of education
  0–5 498 (77.1) 33 (75.0) 1.0
  6–8 85 (13.2) 5 (11.4) 0.88 (0.34–2.34)
  9–13 42 (6.5) 4 (9.1) 1.44 (0.49–4.25)
   13 21 (3.3) 2 (4.5) 1.44 (0.32–6.39)
Living alone 195 (30.2) 11 (25.0) 0.77 (0.38–1.56)
Actual smokers 30 (4.6) 3 (6.8) 1.50 (0.44–5.13)
Alcohol consumption  1/2 wine equivalent liter 15 (2.3) 1 (2.3) 0.99 (0.13–7.58)
Dependency in at least one BADL 198 (30.7) 16 (36.4) 1.29 (0.68–2.44)
Dependency in three or more IADL 461 (71.4) 33 (75.0) 1.20 (0.60–2.43)
Dependency in taking medicine 323 (50.0) 24 (54.5) 1.10 (0.60–2.03)
GDS   5 250 (38.7) 18 (40.9) 1.10 (0.59–2.04)
MMSE   24* 342 (52.9) 29 (65.9) 1.72 (0.91–3.27)
Low self-reported economic income 221 (34.2) 15 (34.1) 0.99 (0.52–1.89)
Need of economic help for health expenses 59 (9.1) 7 (15.9) 1.88 (0.80–4.41)
Informal assistance
  Spouse 113 (17.5) 8 (18.2) 1.05 (0.47–2.31)
  Son/daughter* 210 (32.5) 9 (20.5) 0.53 (0.25–1.10)
  Other relatives 62 (9.6) 7 (15.9) 1.78 (0.76–4.17)
  Foreign caregiver* 93 (14.4) 12 (27.3) 2.23 (1.11–4.48)
  None 34 (5.3) 1 (2.3) 0.42 (0.06–3.13)
Formal assistance
  Nurse 96 (14.9) 7 (15.9) 1.08 (0.47–2.50)
  Assistance for daily activities 136 (21.1) 12 (27.3) 1.40 (0.70–2.80)
Type of admission ward
  Acute care 488 (75.5) 33 (75.0) 1.0
  Long-term/rehabilitation care 158 (24.5) 11 (25.0) 1.03 (0.51–2.08)
Any-listed diagnoses
  Hypertension 442 (68.4) 30 (68.2) 0.99 (0.51–1.90)
  COPD 251 (38.9) 15 (34.1) 0.81 (0.43–1.55)
  Diabetes mellitus* 158 (24.5) 16 (36.4) 1.76 (0.93–3.35)
  Congestive heart failure 141 (21.8) 8 (18.2) 0.80 (0.36–1.75)
  Renal failure* 89 (13.8) 12 (27.3) 2.35 (1.16–4.73)
First-listed diagnoses
  COPD* 87 (13.5) 1 (2.3) 0.14 (0.02–1.10)
  Cerebrovascular disease 59 (9.1) 7 (15.9) 1.88 (0.80–4.41)
  Congestive heart failure 58 (9.0) 3 (6.8) 0.74 (0.22–2.47)
  Hypertension 20 (3.1) 1 (2.3) 0.73 (0.09–5.55)
  Pneumonia* 15 (2.3) 3 (6.8) 3.08 (0.90–11.1)
(Continued)Therapeutics and Clinical Risk Management 2009:5 213
Regimen complexity and medication nonadherence in elderly patients
Table 1 (Continued)
Adherent 
N = 646
Nonadherent 
N = 44
Unadjusted OR 
(95% CI)
Cumulative illness rating scale
 Comorbidity  score 3.8 ± 1.8 4.2 ± 2.3 1.12 (0.96–1.32)
 Severity  score* 1.8 ± 0.4 2.0 ± 0.4 2.22 (1.03–4.77)
Drugs taken before admission
  Overall number of drugs  5* 287 (44.4) 25 (56.8) 1.65 (0.90–3.05)
  At least one multiple daily dosing drug* 396 (61.3) 37 (84.1) 3.34 (1.46–7.60)
  At least one drug taken less than once-a-day 137 (21.2) 11 (25.0) 1.75 (0.59–5.15)
  Use of at least one subcutaneous drug 89 (13.8) 6 (13.6) 0.99 (0.41–2.40)
  Use of at least one inhaled drug 123 (19.0) 7 (15.9) 0.80 (0.35–1.85)
Notes: *Marked variables were signiﬁ  cantly associated with the outcome at p   0.1 level.
Abbreviations: BADL, basic activities of daily living; CI, conﬁ  dence interval; COPD, chronic obstructive pulmonary disease; GDS, Geriatric Depression Scale; IADL, instrumental 
activities of daily living; MMSE, Mini-Mental State Examination; OR, odds ratio.
A cause–effect relationship might explain the observed 
association between being assisted by foreign caregivers and 
the outcome: in a study of patients with Alzheimer’s disease, 
caregivers tend to accurately assess their relatives’ medication 
management abilities, and adherence rates were acceptable, 
but some intervention strategies selected by informal care-
givers were not effective in assuring adequate adherence.38 
Furthermore, cultural barriers may lead foreign caregivers 
to highlight the positive aspects of traditional (eg, medicinal 
plant) in contrast with the shortcomings of modern remedies 
(eg, pharmaceuticals) for health problems.39 These ﬁ  ndings 
suggest that educational interventions aimed at improving 
medication adherence should also target foreign caregivers, 
especially in countries where formal care is poorly available 
and foreign caregivers play a major role as health/social care 
providers.40 Unfortunately, the evidence for effective inter-
ventions to enhance medication adherence in patients with 
multiple chronic conditions is weak, and psychosocial inter-
ventions are generally absent.41 Alternatively, the provision 
of care by a foreign caregiver could not be causally related 
to nonadherence, rather it might simply target the patient at 
risk of nonadherence. Seemingly contradicting this inter-
pretation is the fact that factors proﬁ  ling the patient assisted 
by foreign caregivers (eg, older age, cognitive and physical 
impairment) were individually unrelated to the outcome. 
However, it cannot be excluded that these “frailty” variables, 
taken together, but not individually, qualify as a cumulative 
risk factor. Additionally, the high prevalence of cognitive 
impairment and dependency in IADL might result in a ceiling 
effect preventing any correlation with the outcome.
Age did not correlate with poor compliance. This ﬁ  nding 
conﬁ  rms several observations in different populations.10,42–46 
However, variant results deserve consideration: in two 
hypertensive populations, age has been identiﬁ  ed as a risk fac-
tor for9 or a protective factor against poor compliance.8 Also 
in rheumatoid arthritis patients, older age has been associated 
with better compliance, whereas a busy lifestyle contributed 
signiﬁ  cantly to the clinical proﬁ  le of a nonadherent patient.47 
Similarly, younger age was associated with lower adherence 
in a population of Medicaid beneﬁ  ciaries with congestive 
heart failure,48 and in patients with depression.49 Differences 
in the methods used to measure adherence, in the study 
populations and in the set of collected potential correlates 
of nonadherence likely account for discrepancies. Overall, 
supporting the prevailing evidence, our results state against 
any association between age and nonadherence.
At variance from data reported by Wamala and 
colleagues,16 no social indicator correlated with nonadher-
ence in our population. This might depend upon the age 
of our patients: very old people are burdened with several 
medical conditions which likely overcome the effect of 
social variables on the risk of nonadherence. Furthermore, 
the tight family ties in Italy likely mitigated the impact of 
social disparities on the outcome. Indeed, more than half of 
the enrolled patients were assisted by and 68.3% lived with 
spouse, sons or other relatives in our study.
Limitations deserve to be cited. First, we defined 
nonadherence on the basis of a single question assessment, 
which might underestimate the prevalence of the outcome in 
comparison with other studies.5,8–15 More elaborate question-
naires50,51 may estimate more accurately the prevalence of the 
outcome. However, such an approach would have increased 
the burden of the interview for patients and their relatives/
caregivers in the context of an extensive data collection. Therapeutics and Clinical Risk Management 2009:5 214
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Furthermore, a single question about medication adherence 
has been considered a simple and effective method to iden-
tify nonadherent patients also in other studies.52–54 Second, 
a more detailed neuropsychological assessment of functions 
relevant to the outcome (eg, memory assessment) might have 
disclosed signiﬁ  cant association between cognitive status 
and nonadherence. Indeed, recent evidence suggests that 
memory impairment may worsen medication management 
abilities, thus contributing to unintentional medication non-
adherence.55 Third, our dataset did not allow to investigate 
the possible interaction between taking the same drug more 
than once a day and taking many drugs at different times 
during the day. Fourth, we did not collect information on 
education, linguistic skill, and other characteristics of foreign 
caregivers, which limits our interpretation of the positive 
association between being assisted by a foreign caregiver and 
poor adherence. Finally, our population was enrolled in the 
hospital and therefore our results might not apply to people 
who do not experience a hospital admission.
In conclusion, our results suggest that multiple daily 
dosing might add to the number of prescribed drugs as an 
indicator of regimen complexity affecting adherence. Thus, a 
strategy limiting multiple daily dosing, eg, by using some 
extended release drugs, might be worthy of testing. Most 
important, components of regimen complexity affecting 
adherence and their interaction with other factors, such as the 
source of care, should be carefully investigated. Collaterally, 
the relationship between poor adherence and provision of 
care by a foreign caregiver suggests that strategies promot-
ing medication adherence by dedicated teaching programs 
are desirable. Finally and ﬁ  rst of all, a systematic screening 
of nonadherence should be part of the medical approach to 
geriatric patients.
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